Metabolites from plasma-like medium fuel nitrogen metabolism and influence proliferation in Leptospira interrogans

This study demonstrates that cultivating *Leptospira interrogans* in a physiologically relevant plasma-like medium reveals glutamine as a critical nitrogen source and signaling metabolite that drives bacterial proliferation and biofilm formation, suggesting nitrogen assimilation as a promising therapeutic target for leptospirosis.

The Gist

Imagine Leptospira interrogans as a tiny, shape-shifting invader. It's a bacterium that causes a serious disease called leptospirosis, often spread through floodwaters. For decades, scientists have been trying to figure out how to stop it, but they've been studying it in a "fake" environment—like trying to understand how a fish swims by watching it in a bathtub full of soap instead of the ocean.

This paper is about finally putting that bacterium in the "ocean" (the human body) and discovering exactly what it eats to survive and how we might starve it.

Here is the story of their discovery, broken down into simple concepts:

1. The Wrong Kitchen (The Old Problem)

For years, scientists grew these bacteria in a standard lab dish called EMJH. Think of this dish as a "fast-food menu" for bacteria: it's cheap, easy to make, and keeps the bacteria alive, but it's nothing like the complex, high-end restaurant of the human bloodstream.

• The Analogy: It's like trying to train a marathon runner by having them run on a treadmill in a room with no air. They might move, but they aren't running the way they would in a real race.
• The Result: Because the lab dish was so different from the human body, scientists missed a crucial piece of the puzzle: what the bacteria actually eat inside a human.

2. The Realistic Menu (The New Medium)

The researchers created a new "diet" called sHPLM (supplemented Human Plasma-Like Medium).

• The Analogy: Instead of the fast-food menu, they built a "gourmet meal" that perfectly mimics the nutrients, temperature, and chemistry of human blood.
• The Discovery: When they fed the bacteria this realistic meal, the bacteria didn't just survive; they thrived and acted exactly like they do during a real infection. They grew faster and started behaving like the dangerous invaders they are.

3. The Secret Ingredient (Glutamine)

Using this new "gourmet" diet, the researchers played detective. They tracked what nutrients the bacteria were eating up.

• The Old Belief: Scientists thought the bacteria only ate ammonium (a simple nitrogen source) to build their bodies, like a construction crew using only basic bricks.
• The New Discovery: They found that the bacteria were actually feasting on Glutamine (an amino acid found abundantly in our blood).
• The Analogy: Imagine the bacteria were thought to be eating plain toast for energy. But when you watch them in the real world, you see they are actually devouring a massive steak. Glutamine isn't just a snack; it's their main fuel source for building new cells and multiplying.

4. The "On/Off" Switch (Signaling)

Here is the most surprising twist. The bacteria didn't just eat Glutamine to build themselves; the presence of Glutamine also acted like a light switch or a remote control.

• The Analogy: It's like a car that doesn't just run on gas, but the smell of the gas tells the engine to rev up and go faster.
• The Effect: When the bacteria sensed Glutamine, they immediately sped up their reproduction (proliferation) and started building "fortresses" called biofilms (slime layers that protect them from antibiotics). Even a tiny amount of Glutamine triggered this "go mode."

5. The New Strategy (How to Stop Them)

Now that we know Glutamine is the key, the researchers tested a new way to fight the infection.

• The Strategy: They used a drug called JHU-083, which acts like a "lock" on the door to the bacteria's kitchen. It blocks the bacteria from using Glutamine.
• The Result: When they locked the door, the bacteria stopped growing. It's like cutting off the power supply to a factory; the machines stop, and the building stops expanding.

Why This Matters

This paper is a game-changer because it tells us two big things:

1. Stop studying bacteria in fake conditions: If you want to understand how a germ causes disease, you have to study it in an environment that looks like the human body.
2. New weapons for the future: We might be able to treat severe leptospirosis not just by attacking the bacteria's cell wall (like current antibiotics do), but by starving them of Glutamine or blocking their ability to use it.

In a nutshell: Scientists finally put the bacteria in a realistic setting, discovered it runs on a specific fuel (Glutamine) that acts as a "start button" for infection, and found a way to cut that fuel line to stop the bacteria from multiplying. It's a shift from guessing what the enemy eats to knowing exactly what to take away.

Technical Summary

1. Problem Statement

Leptospirosis, caused by pathogenic Leptospira species (notably L. interrogans), is a re-emerging zoonotic disease with limited effective treatments for severe cases. Current understanding of Leptospira metabolism is largely based on:

• Non-physiological culture conditions: Standard laboratory media (e.g., EMJH) contain supraphysiological concentrations of nutrients (e.g., 4.67 mM ammonium) and lack the complex nutrient profile of the human host.
• Indirect inference: Metabolic pathways have been inferred primarily from genomics, transcriptomics, or proteomics rather than direct metabolite measurement.
• Incomplete nitrogen knowledge: While carbon metabolism (fatty acids) is well-studied, nitrogen assimilation is poorly understood. Previous literature assumed ammonium was the sole nitrogen source, a conclusion drawn from non-physiological media.

The authors posit that these methodological limitations obscure the true metabolic mechanisms driving L. interrogans virulence and proliferation, hindering the discovery of new therapeutic targets.

2. Methodology

The study introduced two major technical innovations to overcome these barriers:

A. Development of Supplemented Human Plasma-Like Medium (sHPLM)

• Formulation: The authors modified commercially available Human Plasma-Like Medium (HPLM) by supplementing it with 10% Fetal Bovine Serum (FBS) and a Bovine Serum Albumin (BSA):oleate conjugate.
• Rationale: This formulation mimics the nutrient concentrations, osmolarity, and temperature (37°C, 5% CO₂) of the human host environment, specifically addressing the requirement for exogenous fatty acids and physiological nitrogen levels.
• Validation: RNA-sequencing (RNA-seq) confirmed that L. interrogans cultured in sHPLM exhibited gene expression profiles (including virulence factors like ligA, lipL41) similar to those observed in in vivo host models, distinct from EMJH-cultured bacteria.

B. LC/MS-Based Metabolomics and Stable Isotope Tracing Workflow

• Sample Processing: A novel vacuum filtration workflow was developed to rapidly separate intracellular metabolites from the complex extracellular medium, preventing contamination and capturing rapid metabolic fluxes.
• Tracing: The team utilized 15N-labeled tracers (15N-ammonium, 15N2-glutamine, 15N-aspartate, 15N2-urea) spiked into sHPLM at 33% labeling.
• Analysis: Liquid Chromatography-Mass Spectrometry (LC/MS) was used to quantify the incorporation of labeled nitrogen into intracellular biomass (amino acids, nucleotides, polyamines) and secreted metabolites over time.
• Inhibition Studies: Small-molecule inhibitors were employed to validate metabolic dependencies:
  • DMA: Inhibits ammonium permease (AmtB).
  • MSO: Inhibits glutamine synthetase (GlnA).
  • JHU-083: A prodrug inhibiting glutamine-utilizing enzymes.

3. Key Contributions

1. Physiological Modeling: Established sHPLM as a superior in vitro model for L. interrogans, inducing a doubling time (4.5 hours) closer to in vivo rates than EMJH (15.5 hours) and triggering host-adaptive gene expression.
2. Direct Metabolic Profiling: Provided the first direct, quantitative measurement of L. interrogans nutrient consumption and nitrogen flux under host-like conditions, moving beyond genomic inference.
3. Redefinition of Nitrogen Metabolism: Challenged the dogma that ammonium is the sole nitrogen source, demonstrating that glutamine is a major, parallel nitrogen donor.
4. Discovery of Signaling Role: Identified glutamine not just as a nutrient, but as a signaling molecule that rapidly induces proliferation and biofilm formation in pathogenic strains.

4. Key Results

A. Nutrient Depletion and Nitrogen Sources

• Depletion Screen: LC/MS analysis of sHPLM revealed that L. interrogans depletes fatty acids, glycerol, cysteine, aspartate, and glutamine.
• Isotope Tracing:
  • Glutamine vs. Ammonium: When cultured with 15N-glutamine, the bacteria incorporated label into nucleotides, amino acids, and polyamines at rates comparable to or exceeding those seen with 15N-ammonium.
  • Direct Uptake: The labeling pattern (M+1 vs. M+2 isotopologues) confirmed that glutamine is directly imported and utilized without needing deamination to ammonium first.
  • Minor Sources: Aspartate and urea were shown to be minor nitrogen sources under these conditions.

B. Metabolic Redundancy and Inhibition

• Inhibitor Sensitivity:
  • Ammonium Blockade: DMA (ammonium transporter inhibitor) blocked proliferation in sHPLM, suggesting ammonium is still required for specific processes.
  • Glutamine Blockade: JHU-083 (glutamine utilization inhibitor) significantly impaired proliferation in sHPLM, confirming glutamine is essential.
  • MSO Resistance: Unlike in EMJH, sHPLM cultures were less sensitive to MSO (glutamine synthetase inhibitor), suggesting that in host-like conditions, the bacteria rely less on synthesizing glutamine from ammonium and more on direct glutamine uptake or alternative assimilation pathways.

C. Glutamine as a Signaling Molecule

• Proliferative Bloom: Adding physiological concentrations of glutamine (550 µM) to EMJH caused a rapid, short-term increase in proliferation (doubling time decreased within 6 hours) and increased final biomass.
• Specificity: This effect was observed in pathogenic strains (L. interrogans Copenhageni and Manilae) but not in the non-pathogenic saprophyte L. biflexa.
• Non-Metabolic Mechanism: The proliferative boost occurred at low glutamine concentrations (5 µM) and was not replicated by ammonium, suggesting a signaling role rather than simple nutrient supplementation.
• Transcriptomic Response: RNA-seq showed upregulation of biosynthetic pathways (cell wall, translation) and downregulation of motility/chemotaxis genes upon glutamine exposure.
• Biofilm Formation: Glutamine exposure significantly increased biofilm formation, an effect not mimicked by ammonium.

5. Significance

• Therapeutic Potential: The study identifies nitrogen metabolism, specifically glutamine utilization, as a critical vulnerability in L. interrogans. The successful inhibition of proliferation using JHU-083 suggests that existing glutamine-targeting drugs (some in clinical trials for other diseases) could be repurposed for leptospirosis.
• Paradigm Shift: The findings necessitate a revision of the metabolic model for Leptospira, moving away from ammonium-centric views to a dual-source model (ammonium + glutamine) that is highly dependent on the physiological environment.
• Methodological Impact: The sHPLM and metabolomics workflow provide a robust framework for studying other fastidious pathogens, ensuring that metabolic discoveries are translatable to in vivo infection scenarios.
• Pathogenesis Insight: The discovery that glutamine acts as a signal to trigger virulence-associated phenotypes (biofilm, rapid replication) offers a new angle for understanding how Leptospira senses and adapts to host environments (e.g., blood vs. urine).